Allspring Global Investments
LXRX icon

Allspring Global Investments’s Lexicon Pharmaceuticals LXRX Stock Holding History

Allspring Global Investments’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,160
Closed -$15.6K – 2867
2022
Q4 		$15.6K Sell
8,160
-179
-2% -$381 ﹤0.01% 2642
2022
Q3 		$20K Sell
8,339
-8,685
-51% -$24K ﹤0.01% 2626
2022
Q2 		$31K Sell
17,024
-186,730
-92% -$356K ﹤0.01% 2387
2022
Q1 		$425K Sell
203,754
-369,745
-64% -$1.02M ﹤0.01% 2289
2021
Q4 		$2.26M Buy
+573,499
New +$2.79M ﹤0.01% 1476

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allspring Global Investments's LXRX Position: Q1 2023 in Review

Allspring Global Investments sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2023, closing a stake of 8,160 shares — an estimated $15.6K sold.

Allspring Global Investments first reported a position in LXRX in Q4 2021 and held it in 5 quarters. The position peaked at $2.26M in Q4 2021. 104 funds tracked by Wall St. Rank hold LXRX as of Q1 2023.

  • Allspring Global Investments reported no remaining Lexicon Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Allspring Global Investments sold 8,160 Lexicon Pharmaceuticals shares in Q1 2023, an estimated $15.6K.
  • Allspring Global Investments first reported a position in Lexicon Pharmaceuticals in Q4 2021 and held it in 5 quarters.
  • Allspring Global Investments's Lexicon Pharmaceuticals position peaked at $2.26M in Q4 2021.
  • 104 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2023.

Based on Allspring Global Investments's 13F filing for Q1 2023, filed 13 Apr 2023.